EXT1
Exostosin-1
Also known as: EXT1_HUMAN, LGCR, LGS, ttv
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16394
- Gene
- EXT1
- Ensembl
- ENSG00000182197
- Chromosome
- 8
- Canonical length
- 746 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes an endoplasmic reticulum-resident type II transmembrane glycosyltransferase involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type I form of multiple exostoses. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
746 residues, UniProt reviewed canonical sequence.
>Q16394|EXT1
1 MQAKKRYFIL LSAGSCLALL FYFGGLQFRA SRSHSRREEH SGRNGLHHPS PDHFWPRFPD
61 ALRPFVPWDQ LENEDSSVHI SPRQKRDANS SIYKGKKCRM ESCFDFTLCK KNGFKVYVYP
121 QQKGEKIAES YQNILAAIEG SRFYTSDPSQ ACLFVLSLDT LDRDQLSPQY VHNLRSKVQS
181 LHLWNNGRNH LIFNLYSGTW PDYTEDVGFD IGQAMLAKAS ISTENFRPNF DVSIPLFSKD
241 HPRTGGERGF LKFNTIPPLR KYMLVFKGKR YLTGIGSDTR NALYHVHNGE DVVLLTTCKH
301 GKDWQKHKDS RCDRDNTEYE KYDYREMLHN ATFCLVPRGR RLGSFRFLEA LQAACVPVML
361 SNGWELPFSE VINWNQAAVI GDERLLLQIP STIRSIHQDK ILALRQQTQF LWEAYFSSVE
421 KIVLTTLEII QDRIFKHISR NSLIWNKHPG GLFVLPQYSS YLGDFPYYYA NLGLKPPSKF
481 TAVIHAVTPL VSQSQPVLKL LVAAAKSQYC AQIIVLWNCD KPLPAKHRWP ATAVPVVVIE
541 GESKVMSSRF LPYDNIITDA VLSLDEDTVL STTEVDFAFT VWQSFPERIV GYPARSHFWD
601 NSKERWGYTS KWTNDYSMVL TGAAIYHKYY HYLYSHYLPA SLKNMVDQLA NCEDILMNFL
661 VSAVTKLPPI KVTQKKQYKE TMMGQTSRAS RWADPDHFAQ RQSCMNTFAS WFGYMPLIHS
721 QMRLDPVLFK DQVSILRKKY RDIERLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EXT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 16 nTPM
- duodenum: 11 nTPM
- small intestine: 9.7 nTPM
- placenta: 9 nTPM
- liver: 8.6 nTPM
- urinary bladder: 8.5 nTPM
Single-cell type
- kupffer cells: 2,691 nCPM
- neutrophils: 2,110 nCPM
- basal keratinocytes: 1,644 nCPM
- epididymal basal cells: 1,627 nCPM
- ocular epithelial cells: 1,595 nCPM
- hepatic stellate cells: 1,523 nCPM
Immune cell
- classical monocyte: 0.2 nTPM
- intermediate monocyte: 0.2 nTPM
- T-reg: 0.2 nTPM
- naive CD8 T-cell: 0.1 nTPM
- NK-cell: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
Brain region
- choroid plexus: 8.9 nTPM
- hippocampal formation: 8 nTPM
- cerebral cortex: 6.1 nTPM
- basal ganglia: 6 nTPM
- cerebellum: 5.8 nTPM
- midbrain: 5.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EXT1.
Disease | AllUniProt
Conditions EXT1 is implicated in, by any mechanism.
- Hereditary multiple exostoses 1 (EXT1) MIM:133700
- Chondrosarcoma (CHDSA) MIM:215300
Disease | GeneticClinVar
528 pathogenic / likely-pathogenic of 1,242 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Multiple congenital exostosis
- Exostoses, multiple, type 1
- Chondrosarcoma
- EXT1-related disorder
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.67
- DepMap mean gene effect
- -0.31
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antigen processing and presentation
- axon guidance
- basement membrane organization
- blood vessel remodeling
- BMP signaling pathway
- bone resorption
- bone trabecula morphogenesis
- canonical Wnt signaling pathway
- cell adhesion mediated by integrin
- cell fate commitment
- cellular response to virus
- chondrocyte differentiation involved in endochondral bone morphogenesis
- chondrocyte hypertrophy
- chondrocyte proliferation
- chondroitin sulfate proteoglycan metabolic process
- collagen fibril organization
- cranial skeletal system development
- dendrite self-avoidance
- dendritic cell migration
- developmental growth involved in morphogenesis
- embryonic skeletal limb joint morphogenesis
- endochondral bone growth
- endochondral ossification
- endoderm development
- epithelial tube branching involved in lung morphogenesis
- ERK1 and ERK2 cascade
- fear response
- fibroblast growth factor receptor signaling pathway
- fluid transport
- gene expression
- glandular epithelial cell differentiation
- glomerular basement membrane development
- glycosaminoglycan biosynthetic process
- hair follicle morphogenesis
- heart contraction
- hematopoietic stem cell differentiation
- hematopoietic stem cell homeostasis
- hematopoietic stem cell migration to bone marrow
- heparan sulfate proteoglycan biosynthetic process
- heparin proteoglycan biosynthetic process
- leukocyte tethering or rolling
- limb bud formation
- lymphocyte migration into lymphoid organs
- mesenchymal cell differentiation involved in bone development
- mesodermal cell differentiation
- motor behavior
- multicellular organism growth
- multicellular organismal-level water homeostasis
- neural crest cell differentiation
- olfactory bulb development
- optic nerve development
- ossification
- ossification involved in bone maturation
- outflow tract morphogenesis
- podocyte differentiation
- polysaccharide biosynthetic process
- protein catabolic process
- protein-containing complex assembly
- regulation of blood pressure
- regulation of tumor necrosis factor-mediated signaling pathway
- response to heparin
- response to leukemia inhibitory factor
- response to light intensity
- sebaceous gland development
- social behavior
- sodium ion homeostasis
- stem cell division
- stomach development
- sulfation
- synaptic transmission, glutamatergic
- tight junction organization
- vacuole organization
- vasodilation
- vocalization behavior
- wound healing
- heart field specification
- hypersensitivity
- lymphocyte adhesion to endothelial cell of high endothelial venule
- perichondral bone morphogenesis
- smoothened signaling pathway involved in lung development
- sweat gland development
Molecular functions
- acetylglucosaminyltransferase activity
- glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity
- glucuronosyltransferase activity
- heparan sulfate N-acetylglucosaminyltransferase activity
- metal ion binding
- N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity
- protein heterodimerization activity
- protein homodimerization activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EXT1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EXT1 as an antibody target. Whether an autoantibody or antibody against EXT1 could matter depends on whether native EXT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EXT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EXT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...